Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
25%
Ph phase_4
3
38%
Ph not_applicable
3
38%

Phase Distribution

0

Early Stage

0

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
3(37.5%)
N/ANon-phased studies
3(37.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(2)
Completed(3)
Other(3)

Detailed Status

Completed3
unknown3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (25.0%)
Phase 43 (37.5%)
N/A3 (37.5%)

Trials by Status

completed338%
recruiting225%
unknown338%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8